Home NDC 42227-081 Cinryze
Product NDC 42227-081
11-digit product format 422270081
Labeler code 42227
Product ID 42227-081_421ea216-278f-4ca8-ae5d-5dafe85658a0
Type PLASMA DERIVATIVE
Nonproprietary name HUMAN C1-ESTERASE INHIBITOR
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Takeda Pharmaceuticals America, Inc.
Application BLA125267
Marketing category BLA
Marketing start 2008-12-01
Substance HUMAN C1-ESTERASE INHIBITOR
Active strength 500 [iU]/5mL
Pharmacologic classes Decreased Vascular Permeability [PE], Human C1 Esterase Inhibitor [EPC], Kallikrein Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Cinryze
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength HUMAN C1-ESTERASE INHIBITOR 500 [iU]/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 6KIC4BB60G Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 809871 Internal RxNorm lookup 1729336 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42227-081-01 Cinryze 5 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, LYOPHILIZED, 5 mL 500 [iU] in 5mL 42 42227-081-01 Cinryze 5 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, LYOPHILIZED, 5 42
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HUMAN C1-ESTERASE INHIBITOR ACTIVE INGREDIENT 6KIC4BB60G CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23 HUMAN C1-ESTERASE INHIBITOR ACTIVE MOIETY 6KIC4BB60G CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23 ALANINE INACTIVE INGREDIENT OF5P57N2ZX CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23 SUCROSE INACTIVE INGREDIENT C151H8M554 CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23 THREONINE INACTIVE INGREDIENT 2ZD004190S CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23 TRISODIUM CITRATE DIHYDRATE INACTIVE INGREDIENT B22547B95K CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23 VALINE INACTIVE INGREDIENT HG18B9YRS7 CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [VIROPHARMA BIOLOGICS] 23
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42227-081 CINRYZE (HUMAN C1-ESTERASE INHIBITOR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CINRYZE (HUMAN C1-ESTERASE INHIBITOR) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] 41 Current NDC, Legacy NDC, 1 package rows 20241224_d53a911f-070d-498a-8a61-baab72b9d0fe.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Cinryze HUMAN C1-ESTERASE INHIBITOR Takeda Pharmaceuticals America, Inc. d53a911f-070d-498a-8a61-baab72b9d0fe 2025-11-28 Warnings, Adverse reactions Exact identifier application number: BLA125267 ndc (product): 42227-081
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125267 Cinryze C1 Esterase Inhibitor (Human) 351(a) Rx 2026-10-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 42227-081-01 42227008101 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) 5 ml 2008-12-01 No No Current 42227-081-05 42227008105 1 VIAL, SINGLE-USE in 1 CARTON (42227-081-05) > 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) 2008-12-01 0000-00-00 No No Current